SEC Form 4 · accession 0000904454-18-000386
Esperion Therapeutics, Inc. · ESPR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nicole Vitullo
Director
Period of report
May 23, 2018
Accepted (ET)
May 25, 2018 · 4:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001434868
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $38.32 | May 23, 2018 | A | 10,100 | A | — | May 23, 2028 | Common Stock | 10,100 | 10,100 | D |
Explanation of responses
- F1The option vests in full on the earlier of the one year anniversary of the date of grant or the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service on the Board of Directors at such time.